Re: ZHCLF up 290% to $0.16...question
in response to
by
posted on
Dec 17, 2020 11:03AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
I would like to know from Josh if he sold any ZHCLF. Is it easier buying in than selling out?
(Stock liquidity?)
Koo